These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29756724)

  • 1. Stevens-Johnson Syndrome associated with methotrexate treatment for acute lymphoblastic leukemia: a case report.
    Akıncı B; Siviş ZÖ; Şahin A; Karapınar DY; Balkan C; Kavaklı K; Aydınok Y
    Arch Argent Pediatr; 2018 Jun; 116(3):e459-e462. PubMed ID: 29756724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate might become the sole treatment option for leukemia following the occurrence of Stevens-Johnson syndrome.
    Aranda CS; Silvestre KMC; Marques KDS; Lee ML; Solé D
    Allergol Immunopathol (Madr); 2024; 52(4):81-83. PubMed ID: 38970269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic epidermal necrolysis and graft vs. host disease: a clinical spectrum but a diagnostic dilemma.
    Stone N; Sheerin S; Burge S
    Clin Exp Dermatol; 1999 Jul; 24(4):260-2. PubMed ID: 10457124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole.
    Yang CH; Yang LJ; Jaing TH; Chan HL
    Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside.
    Ozkan A; Apak H; Celkan T; Yüksel L; Yildiz I
    Pediatr Dermatol; 2001; 18(1):38-40. PubMed ID: 11207969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Kaur-Knudsen D; Zachariae C; Thomsen SF
    Ugeskr Laeger; 2013 Dec; 175(50):3096-9. PubMed ID: 24629532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution.
    Sibbald C; Putterman E; Micheletti R; Treat J; Castelo-Soccio L
    Pediatr Dermatol; 2020 May; 37(3):461-466. PubMed ID: 32058621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus-disease-2019-associated Stevens-Johnsons syndrome in a 15-year-old boy: a case report and review of the literature.
    Li N; Li J
    J Med Case Rep; 2024 Oct; 18(1):493. PubMed ID: 39390502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Should Be Kept in Mind in Children with Febrile Neutropenia, Oral Cavity Lesions, and Skin Rash.
    Ataseven E; Yılmaz Bengoa Ş; Ören H
    Turk J Haematol; 2016 Jun; 33(2):170-1. PubMed ID: 26376920
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid remission of Stevens-Johnson syndrome by combination therapy using etanercept and intravenous immunoglobulin and a review of the literature.
    Wang R; Zhong S; Tu P; Li R; Wang M
    Dermatol Ther; 2019 Jul; 32(4):e12832. PubMed ID: 30659711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
    Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV
    Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children With Non-Hodgkin Lymphoma.
    Kara B; Gungorer V; Akyurek FT; Koksal Y
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e310-e314. PubMed ID: 32576784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Kühn-Córdova I; Ramírez-Bouchan D; Gamboa-Marrufo JD
    An Pediatr (Barc); 2007 Jul; 67(1):68-73. PubMed ID: 17663910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
    Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
    Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel complication of Flakka: Stevens-Johnson syndrome/Toxic epidermal necrolysis overlap.
    İlhan B; Doğan H; Şahin EA; Karslıoğlu N; Koçak Ö
    Am J Emerg Med; 2019 Mar; 37(3):562.e1-562.e3. PubMed ID: 30503281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Prescrire Int; 2014 Jun; 23(150):157. PubMed ID: 25121151
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.